The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Vagal Nerve Stimulators Market Research Report 2024
Synopsis
Vagus nerve stimulation (VNS) is a medical treatment that involves delivering electrical impulses to the vagus nerve.
The global Vagal Nerve Stimulators market was valued at US$ 681.2 million in 2023 and is anticipated to reach US$ 1137.6 million by 2030, witnessing a CAGR of 7.6% during the forecast period 2024-2030.
These devices are used for therapeutic purposes in neurology and pain management, delivering low-frequency electrical stimulation to targeted areas of the nervous system. The market growth can be attributed to several factors. Firstly, the increasing prevalence of neurological disorders and chronic pain conditions has created a demand for non-invasive and drug-free treatment options. Low-frequency sine wave neurostimulation therapy devices offer a safe and effective approach for managing these conditions, providing pain relief and improving overall quality of life for patients.
This report aims to provide a comprehensive presentation of the global market for Vagal Nerve Stimulators, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vagal Nerve Stimulators.
Report Scope
The Vagal Nerve Stimulators market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vagal Nerve Stimulators market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vagal Nerve Stimulators manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Boston Scientific
Abbott
Truvaga Nerve Stimulation
NeuroPace
Segment by Type
Rechargeable spinal-cord stimulator
Non-chargeable spinal-cord stimulator
Segment by Application
Parkinson's disease
Epilepsy
Pain
Other
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vagal Nerve Stimulators manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vagal Nerve Stimulators in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Vagus nerve stimulation (VNS) is a medical treatment that involves delivering electrical impulses to the vagus nerve.
The global Vagal Nerve Stimulators market was valued at US$ 681.2 million in 2023 and is anticipated to reach US$ 1137.6 million by 2030, witnessing a CAGR of 7.6% during the forecast period 2024-2030.
These devices are used for therapeutic purposes in neurology and pain management, delivering low-frequency electrical stimulation to targeted areas of the nervous system. The market growth can be attributed to several factors. Firstly, the increasing prevalence of neurological disorders and chronic pain conditions has created a demand for non-invasive and drug-free treatment options. Low-frequency sine wave neurostimulation therapy devices offer a safe and effective approach for managing these conditions, providing pain relief and improving overall quality of life for patients.
This report aims to provide a comprehensive presentation of the global market for Vagal Nerve Stimulators, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vagal Nerve Stimulators.
Report Scope
The Vagal Nerve Stimulators market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vagal Nerve Stimulators market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vagal Nerve Stimulators manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Boston Scientific
Abbott
Truvaga Nerve Stimulation
NeuroPace
Segment by Type
Rechargeable spinal-cord stimulator
Non-chargeable spinal-cord stimulator
Segment by Application
Parkinson's disease
Epilepsy
Pain
Other
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vagal Nerve Stimulators manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vagal Nerve Stimulators in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Vagal Nerve Stimulators Market Overview
1.1 Product Overview and Scope of Vagal Nerve Stimulators
1.2 Vagal Nerve Stimulators Segment by Type
1.2.1 Global Vagal Nerve Stimulators Market Value Comparison by Type (2024-2030)
1.2.2 Rechargeable spinal-cord stimulator
1.2.3 Non-chargeable spinal-cord stimulator
1.3 Vagal Nerve Stimulators Segment by Application
1.3.1 Global Vagal Nerve Stimulators Market Value by Application: (2024-2030)
1.3.2 Parkinson's disease
1.3.3 Epilepsy
1.3.4 Pain
1.3.5 Other
1.4 Global Vagal Nerve Stimulators Market Size Estimates and Forecasts
1.4.1 Global Vagal Nerve Stimulators Revenue 2019-2030
1.4.2 Global Vagal Nerve Stimulators Sales 2019-2030
1.4.3 Global Vagal Nerve Stimulators Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Vagal Nerve Stimulators Market Competition by Manufacturers
2.1 Global Vagal Nerve Stimulators Sales Market Share by Manufacturers (2019-2024)
2.2 Global Vagal Nerve Stimulators Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Vagal Nerve Stimulators Average Price by Manufacturers (2019-2024)
2.4 Global Vagal Nerve Stimulators Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vagal Nerve Stimulators, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vagal Nerve Stimulators, Product Type & Application
2.7 Vagal Nerve Stimulators Market Competitive Situation and Trends
2.7.1 Vagal Nerve Stimulators Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Vagal Nerve Stimulators Players Market Share by Revenue
2.7.3 Global Vagal Nerve Stimulators Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vagal Nerve Stimulators Retrospective Market Scenario by Region
3.1 Global Vagal Nerve Stimulators Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Vagal Nerve Stimulators Global Vagal Nerve Stimulators Sales by Region: 2019-2030
3.2.1 Global Vagal Nerve Stimulators Sales by Region: 2019-2024
3.2.2 Global Vagal Nerve Stimulators Sales by Region: 2025-2030
3.3 Global Vagal Nerve Stimulators Global Vagal Nerve Stimulators Revenue by Region: 2019-2030
3.3.1 Global Vagal Nerve Stimulators Revenue by Region: 2019-2024
3.3.2 Global Vagal Nerve Stimulators Revenue by Region: 2025-2030
3.4 North America Vagal Nerve Stimulators Market Facts & Figures by Country
3.4.1 North America Vagal Nerve Stimulators Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Vagal Nerve Stimulators Sales by Country (2019-2030)
3.4.3 North America Vagal Nerve Stimulators Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Vagal Nerve Stimulators Market Facts & Figures by Country
3.5.1 Europe Vagal Nerve Stimulators Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Vagal Nerve Stimulators Sales by Country (2019-2030)
3.5.3 Europe Vagal Nerve Stimulators Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vagal Nerve Stimulators Market Facts & Figures by Country
3.6.1 Asia Pacific Vagal Nerve Stimulators Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Vagal Nerve Stimulators Sales by Country (2019-2030)
3.6.3 Asia Pacific Vagal Nerve Stimulators Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Vagal Nerve Stimulators Market Facts & Figures by Country
3.7.1 Latin America Vagal Nerve Stimulators Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Vagal Nerve Stimulators Sales by Country (2019-2030)
3.7.3 Latin America Vagal Nerve Stimulators Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vagal Nerve Stimulators Market Facts & Figures by Country
3.8.1 Middle East and Africa Vagal Nerve Stimulators Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Vagal Nerve Stimulators Sales by Country (2019-2030)
3.8.3 Middle East and Africa Vagal Nerve Stimulators Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vagal Nerve Stimulators Sales by Type (2019-2030)
4.1.1 Global Vagal Nerve Stimulators Sales by Type (2019-2024)
4.1.2 Global Vagal Nerve Stimulators Sales by Type (2025-2030)
4.1.3 Global Vagal Nerve Stimulators Sales Market Share by Type (2019-2030)
4.2 Global Vagal Nerve Stimulators Revenue by Type (2019-2030)
4.2.1 Global Vagal Nerve Stimulators Revenue by Type (2019-2024)
4.2.2 Global Vagal Nerve Stimulators Revenue by Type (2025-2030)
4.2.3 Global Vagal Nerve Stimulators Revenue Market Share by Type (2019-2030)
4.3 Global Vagal Nerve Stimulators Price by Type (2019-2030)
5 Segment by Application
5.1 Global Vagal Nerve Stimulators Sales by Application (2019-2030)
5.1.1 Global Vagal Nerve Stimulators Sales by Application (2019-2024)
5.1.2 Global Vagal Nerve Stimulators Sales by Application (2025-2030)
5.1.3 Global Vagal Nerve Stimulators Sales Market Share by Application (2019-2030)
5.2 Global Vagal Nerve Stimulators Revenue by Application (2019-2030)
5.2.1 Global Vagal Nerve Stimulators Revenue by Application (2019-2024)
5.2.2 Global Vagal Nerve Stimulators Revenue by Application (2025-2030)
5.2.3 Global Vagal Nerve Stimulators Revenue Market Share by Application (2019-2030)
5.3 Global Vagal Nerve Stimulators Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Vagal Nerve Stimulators Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic Vagal Nerve Stimulators Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Corporation Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Vagal Nerve Stimulators Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boston Scientific Vagal Nerve Stimulators Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Vagal Nerve Stimulators Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abbott Vagal Nerve Stimulators Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Truvaga Nerve Stimulation
6.4.1 Truvaga Nerve Stimulation Corporation Information
6.4.2 Truvaga Nerve Stimulation Description and Business Overview
6.4.3 Truvaga Nerve Stimulation Vagal Nerve Stimulators Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Truvaga Nerve Stimulation Vagal Nerve Stimulators Product Portfolio
6.4.5 Truvaga Nerve Stimulation Recent Developments/Updates
6.5 NeuroPace
6.5.1 NeuroPace Corporation Information
6.5.2 NeuroPace Description and Business Overview
6.5.3 NeuroPace Vagal Nerve Stimulators Sales, Revenue and Gross Margin (2019-2024)
6.5.4 NeuroPace Vagal Nerve Stimulators Product Portfolio
6.5.5 NeuroPace Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vagal Nerve Stimulators Industry Chain Analysis
7.2 Vagal Nerve Stimulators Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vagal Nerve Stimulators Production Mode & Process
7.4 Vagal Nerve Stimulators Sales and Marketing
7.4.1 Vagal Nerve Stimulators Sales Channels
7.4.2 Vagal Nerve Stimulators Distributors
7.5 Vagal Nerve Stimulators Customers
8 Vagal Nerve Stimulators Market Dynamics
8.1 Vagal Nerve Stimulators Industry Trends
8.2 Vagal Nerve Stimulators Market Drivers
8.3 Vagal Nerve Stimulators Market Challenges
8.4 Vagal Nerve Stimulators Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
